$CHTH
CNL Healthcare Properties, Inc.

2021 Q3 Form 10-Q Financial Statement

#000095017021001338 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $74.18M $73.33M $78.39M
YoY Change -2.65% -6.46% -2.19%
Cost Of Revenue $52.71M $50.46M $52.23M
YoY Change 1.11% -3.38% 0.71%
Gross Profit $21.48M $22.87M $26.17M
YoY Change -10.79% -12.61% -7.51%
Gross Profit Margin 28.95% 31.18% 33.38%
Selling, General & Admin $5.804M $6.385M $7.114M
YoY Change -14.45% -10.25% -27.51%
% of Gross Profit 27.02% 27.92% 27.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.50M $12.20M $12.40M
YoY Change -12.59% -1.61% 0.43%
% of Gross Profit 58.2% 53.35% 47.39%
Operating Expenses $887.0K $720.0K $1.062M
YoY Change 0.11% -32.2% -27.85%
Operating Profit $3.033M $4.175M $6.598M
YoY Change 4.08% -36.72% 3.77%
Interest Expense -$5.047M -$4.612M -$5.807M
YoY Change -4.3% -20.58% -45.57%
% of Operating Profit -166.4% -110.47% -88.01%
Other Income/Expense, Net -$5.047M -$4.612M -$5.807M
YoY Change -4.3% -20.58%
Pretax Income -$2.014M -$437.0K $791.0K
YoY Change -185.34% -155.25% -118.35%
Income Tax -$1.500M -$1.000M $800.0K
% Of Pretax Income 101.14%
Net Earnings -$533.0K $594.0K $220.0K
YoY Change -69.33% 170.0% -99.93%
Net Earnings / Revenue -0.72% 0.81% 0.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.064K $3.415K $1.265K
COMMON SHARES
Basic Shares Outstanding 174.0M 174.0M
Diluted Shares Outstanding 174.0M shares

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.55M $65.17M $143.9M
YoY Change -20.57% -54.7% 173.46%
Cash & Equivalents $55.55M $65.17M $150.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $55.55M $65.17M $143.9M
YoY Change -20.57% -54.7% 173.46%
LONG-TERM ASSETS
Property, Plant & Equipment $1.364B $1.372B $1.392B
YoY Change -2.52% -1.4% -2.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.02M $18.45M $51.27M
YoY Change -40.09% -64.02% -69.87%
Total Long-Term Assets $1.410B $1.414B $1.473B
YoY Change -3.25% -4.02% -9.61%
TOTAL ASSETS
Total Short-Term Assets $55.55M $65.17M $143.9M
Total Long-Term Assets $1.410B $1.414B $1.473B
Total Assets $1.466B $1.479B $1.617B
YoY Change -4.05% -8.53% -3.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.37M $25.96M $23.53M
YoY Change -6.04% 10.32% 0.42%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.96M $27.35M $26.18M
YoY Change -7.05% 4.49% 1.81%
LONG-TERM LIABILITIES
Long-Term Debt $590.1M $595.0M $693.4M
YoY Change -3.37% -14.19% -6.29%
Other Long-Term Liabilities $6.358M $6.689M $8.939M
YoY Change -22.46% -25.17% -17.51%
Total Long-Term Liabilities $596.5M $601.7M $702.3M
YoY Change -3.62% -14.33% -6.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.96M $27.35M $26.18M
Total Long-Term Liabilities $596.5M $601.7M $702.3M
Total Liabilities $625.4M $629.0M $730.4M
YoY Change -4.06% -13.88% -5.94%
SHAREHOLDERS EQUITY
Retained Earnings $122.7M $123.2M
YoY Change -1.13%
Common Stock $1.519B $1.519B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $838.7M $848.2M $886.4M
YoY Change
Total Liabilities & Shareholders Equity $1.466B $1.479B $1.617B
YoY Change -4.05% -8.53% -3.89%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$533.0K $594.0K $220.0K
YoY Change -69.33% 170.0% -99.93%
Depreciation, Depletion And Amortization $12.50M $12.20M $12.40M
YoY Change -12.59% -1.61% 0.43%
Cash From Operating Activities $8.719M $11.56M $14.15M
YoY Change -43.7% -18.31% -61.74%
INVESTING ACTIVITIES
Capital Expenditures -$4.384M -$1.973M -$1.235M
YoY Change 117.78% 59.76% -39.01%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$4.997M
YoY Change -100.0% -100.0% -100.38%
Cash From Investing Activities -$4.384M -$1.973M -$6.232M
YoY Change -245.65% -68.34% -100.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.01M -11.74M 28.43M
YoY Change -84.74% -141.3% -102.1%
NET CHANGE
Cash From Operating Activities 8.719M 11.56M 14.15M
Cash From Investing Activities -4.384M -1.973M -6.232M
Cash From Financing Activities -14.01M -11.74M 28.43M
Net Change In Cash -9.673M -2.155M 36.35M
YoY Change -86.8% -105.93% -864.5%
FREE CASH FLOW
Cash From Operating Activities $8.719M $11.56M $14.15M
Capital Expenditures -$4.384M -$1.973M -$1.235M
Free Cash Flow $13.10M $13.53M $15.39M
YoY Change -25.12% -12.04% -60.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
259000
CY2020Q4 chth Excess Stock Value
ExcessStockValue
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 chth Disposal Fees
DisposalFees
CY2021Q2 chth Disposal Group Liabilities On Assets Held For Sale
DisposalGroupLiabilitiesOnAssetsHeldForSale
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q2 chth Excess Stock Value
ExcessStockValue
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001496454
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:HealthCareResidentServiceMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54685
dei Entity Registrant Name
EntityRegistrantName
CNL Healthcare Properties, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2876363
dei Entity Address Address Line1
EntityAddressAddressLine1
CNL Center at City Commons
dei Entity Address Address Line2
EntityAddressAddressLine2
450 South Orange Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
650-1000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173960540
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1372055000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1392860000
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
7421000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65168000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61475000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4973000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4536000
CY2021Q2 us-gaap Other Assets
OtherAssets
23188000
CY2020Q4 us-gaap Other Assets
OtherAssets
23341000
CY2021Q2 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
13477000
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
14408000
CY2021Q2 us-gaap Assets
Assets
1478861000
CY2020Q4 us-gaap Assets
Assets
1504041000
CY2021Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
331315000
CY2020Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
336685000
CY2021Q2 us-gaap Line Of Credit
LineOfCredit
263660000
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
263423000
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
25961000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
24519000
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
6689000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
8255000
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1393000
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1780000
CY2020Q4 chth Disposal Group Liabilities On Assets Held For Sale
DisposalGroupLiabilitiesOnAssetsHeldForSale
10000
CY2021Q2 us-gaap Liabilities
Liabilities
629018000
CY2020Q4 us-gaap Liabilities
Liabilities
634672000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
505000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
572000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2020Q4 chth Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2020Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
300000000
CY2021Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2020Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0
CY2021Q2 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2020Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1120000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186626000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173960000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1740000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1740000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1516926000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
123190000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
124743000
CY2021Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
793679000
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
775866000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
848152000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
867508000
CY2021Q2 us-gaap Minority Interest
MinorityInterest
1186000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1289000
CY2021Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
849843000
CY2020Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
869369000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1478861000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1504041000
CY2021Q2 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
7461000
CY2020Q2 chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
6814000
chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
14735000
chth Rental Income And Related Revenues
RentalIncomeAndRelatedRevenues
14936000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65868000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71577000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130677000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145199000
CY2021Q2 us-gaap Revenues
Revenues
73329000
CY2020Q2 us-gaap Revenues
Revenues
78391000
us-gaap Revenues
Revenues
145412000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2625000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4519000
us-gaap Revenues
Revenues
160135000
CY2021Q2 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
47343000
CY2020Q2 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
48889000
us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
95198000
us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
97135000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2271000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4758000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12307000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12454000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24944000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24998000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
69154000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
71793000
us-gaap Costs And Expenses
CostsAndExpenses
139433000
us-gaap Costs And Expenses
CostsAndExpenses
142830000
CY2021Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
CY2020Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1074000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4175000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6598000
us-gaap Operating Income Loss
OperatingIncomeLoss
5979000
us-gaap Operating Income Loss
OperatingIncomeLoss
18379000
CY2021Q2 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
392000
CY2020Q2 chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
101000
chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
390000
chth Interest And Other Income Expense
InterestAndOtherIncomeExpense
132000
CY2021Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
5260000
CY2020Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
6108000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
10541000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
13184000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
256000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
237000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
406000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4612000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5807000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9914000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12646000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-437000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
791000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3935000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5733000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1023000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
769000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
586000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
246000
us-gaap Profit Loss
ProfitLoss
-1586000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2359000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1325000
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
586000
CY2020Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
22000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1576000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4408000
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
224000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-10000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
616000
us-gaap Profit Loss
ProfitLoss
5024000
CY2021Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-8000
CY2020Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
26000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-33000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
62000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
594000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
220000
us-gaap Net Income Loss
NetIncomeLoss
-1553000
us-gaap Net Income Loss
NetIncomeLoss
4962000
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.03
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173960000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
586000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
246000
us-gaap Profit Loss
ProfitLoss
-1586000
us-gaap Profit Loss
ProfitLoss
5024000
CY2021Q2 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
5000
CY2020Q2 chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
5000
chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
6000
chth Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax Excluding Equity Method Investments
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTaxExcludingEquityMethodInvestments
9000
CY2021Q2 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
2000
CY2020Q2 chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
0
chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
4000
chth Other Comprehensive Income Loss Unrealized Gain Loss On Derivative Instruments Of Equity Method Investments Portion Attributable To Parent
OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativeInstrumentsOfEquityMethodInvestmentsPortionAttributableToParent
-14000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
593000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
251000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1576000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5019000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
26000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-33000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
62000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
601000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
225000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1543000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4957000
CY2021Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
858184000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
586000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
28000
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05120
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8906000
CY2021Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
849843000
CY2020Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
869369000
us-gaap Profit Loss
ProfitLoss
-1586000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
137000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10240
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17813000
CY2021Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
849843000
CY2020Q1 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
896873000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
246000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
65000
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05120
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8907000
CY2020Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
75000
CY2020Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
888227000
CY2019Q4 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
901031000
us-gaap Profit Loss
ProfitLoss
5024000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
85000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10240
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17813000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
75000
CY2020Q2 chth Stockholders Equity And Temporary Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityAndTemporaryEquityIncludingPortionAttributableToNoncontrollingInterest
888227000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
24200000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
31309000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-7000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
702000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24193000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32011000
chth Proceeds From Sale Of Real Estate Discontinued Operations
ProceedsFromSaleOfRealEstateDiscontinuedOperations
0
chth Proceeds From Sale Of Real Estate Discontinued Operations
ProceedsFromSaleOfRealEstateDiscontinuedOperations
53712000
chth Payments For Capital Expenditure Discontinued Operations
PaymentsForCapitalExpenditureDiscontinuedOperations
3948000
chth Payments For Capital Expenditure Discontinued Operations
PaymentsForCapitalExpenditureDiscontinuedOperations
3734000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4997000
chth Payments For Proceeds From Other Investing Activities Discontinued Operations
PaymentsForProceedsFromOtherInvestingActivitiesDiscontinuedOperations
-35000
chth Payments For Proceeds From Other Investing Activities Discontinued Operations
PaymentsForProceedsFromOtherInvestingActivitiesDiscontinuedOperations
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3913000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
44981000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
7402000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
28398000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3489000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
73379000
us-gaap Payments Of Dividends
PaymentsOfDividends
17813000
us-gaap Payments Of Dividends
PaymentsOfDividends
17813000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
40000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5601000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
26065000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-138000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
43000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23552000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3875000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4130000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
101515000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66011000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48537000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70141000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150052000
CY2018Q4 chth Number Of Properties
NumberOfProperties
70
CY2018Q4 chth Number Of Properties Sold
NumberOfPropertiesSold
63
CY2018Q4 chth Number Of Skilled Nursing Facilities Held For Sale
NumberOfSkilledNursingFacilitiesHeldForSale
7
CY2019 chth Number Of Properties Sold
NumberOfPropertiesSold
61
CY2020 chth Number Of Properties Sold
NumberOfPropertiesSold
7
us-gaap Use Of Estimates
UseOfEstimates
<p id="xbrl_ts_699aa1c389e94ae99ac3ba1db7db33aa" style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> —</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock (“Restricted Stock”) shares issued to the Advisor. Accordingly, actual results could differ from those estimates.</span></p>
CY2021Q2 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6080
CY2020Q2 chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6080
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65900000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71600000
CY2021Q2 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2020Q2 chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6080
chth Revenue Recognition Number Of Facility
RevenueRecognitionNumberOfFacility
6080
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145200000
chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
chth Percentage Of Contract Related Revenue
PercentageOfContractRelatedRevenue
1.000
CY2021Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
132896000
CY2020Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
132663000
CY2021Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1504219000
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1501107000
CY2021Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
94682000
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
94141000
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
359742000
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
335051000
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1372055000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1392860000
CY2021Q2 us-gaap Depreciation
Depreciation
12200000
us-gaap Depreciation
Depreciation
24700000
CY2020Q2 us-gaap Depreciation
Depreciation
12400000
us-gaap Depreciation
Depreciation
24800000
CY2019 chth Number Of Properties Held For Sale
NumberOfPropertiesHeldForSale
61
CY2019 chth Number Of Other Properties
NumberOfOtherProperties
8
chth Number Of Properties Sold
NumberOfPropertiesSold
6
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1100000
chth Number Of Post Acute Care Properties
NumberOfPostAcuteCareProperties
1
CY2020 chth Number Of Acute Care Properties
NumberOfAcuteCareProperties
1
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2020Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
257000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
6000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
855000
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
0
CY2020Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
33000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
19000
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
239000
CY2021Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2020Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
224000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-13000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
616000
CY2021Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2020Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-3000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
224000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-10000
chth Number Of Debt Collateralized Properties
NumberOfDebtCollateralizedProperties
22
CY2020 chth Number Of Debt Collateralized Properties
NumberOfDebtCollateralizedProperties
22
CY2021Q2 chth Line Of Credit Facility Current Undrawn Capacity
LineOfCreditFacilityCurrentUndrawnCapacity
250000000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
616000
CY2021Q2 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
12800000
CY2021Q2 chth Liquidity
Liquidity
148900000
CY2021Q2 us-gaap Cash
Cash
65200000
chth Annual Taxes And Insurance Premiums
AnnualTaxesAndInsurancePremiums
6000000.0
us-gaap Debt Instrument Restrictive Covenants
DebtInstrumentRestrictiveCovenants
The credit facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the credit facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the credit facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of June 30, 2021, the Company was in compliance with all financial covenants related to its Credit Facilities.
chth Financial Covenant Limitations Maximum Allowable Distributions As Percentage Of Adjusted Funds From Operations
FinancialCovenantLimitationsMaximumAllowableDistributionsAsPercentageOfAdjustedFundsFromOperations
0.95
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
720000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
1062000
us-gaap Operating Expenses
OperatingExpenses
1473000
us-gaap Operating Expenses
OperatingExpenses
1730000
CY2021Q2 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
259000
CY2020Q4 chth Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
275000
CY2021Q2 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
720000
CY2020Q2 chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
1062000
chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
1473000
chth Related Party Transaction Cost Of Reimbursable Expense
RelatedPartyTransactionCostOfReimbursableExpense
1730000
CY2020Q4 chth Reimbursable Offering Expenses Due Related Party
ReimbursableOfferingExpensesDueRelatedParty
275000
CY2021Q2 chth Disposal Cost
DisposalCost
0
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
11036000
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1393000
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1780000
CY2020Q2 chth Disposal Cost
DisposalCost
0
chth Disposal Cost
DisposalCost
0
chth Disposal Cost
DisposalCost
143000
CY2021Q2 chth Disposal Fees
DisposalFees
0
CY2021Q2 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
4113000
CY2020Q2 chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
4513000
chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
8590000
chth Related Party Transaction Asset Management Costs
RelatedPartyTransactionAssetManagementCosts
9163000
CY2021Q2 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1134000
CY2020Q4 chth Due To Related Party Asset Management Fees
DueToRelatedPartyAssetManagementFees
1505000
CY2021Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4833000
CY2020Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5575000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10063000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000.0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2400000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000
CY2021Q2 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1200000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
2600000
CY2021Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-200000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-200000
CY2020Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-200000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-300000
CY2020Q2 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-600000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-1000000.0
CY2021Q2 chth Number Of Promoted Interest Agreements
NumberOfPromotedInterestAgreements
2
CY2021Q2 chth Number Of Promoted Interest Agreements Met Established Performance Metrics
NumberOfPromotedInterestAgreementsMetEstablishedPerformanceMetrics
0

Files In Submission

Name View Source Status
0000950170-21-001338-index-headers.html Edgar Link pending
0000950170-21-001338-index.html Edgar Link pending
0000950170-21-001338.txt Edgar Link pending
0000950170-21-001338-xbrl.zip Edgar Link pending
chth-20210630.htm Edgar Link pending
chth-20210630.xsd Edgar Link pending
chth-20210630ex31_1.htm Edgar Link pending
chth-20210630ex31_2.htm Edgar Link pending
chth-20210630ex32_1.htm Edgar Link pending
chth-20210630_cal.xml Edgar Link unprocessable
chth-20210630_def.xml Edgar Link unprocessable
chth-20210630_htm.xml Edgar Link completed
chth-20210630_lab.xml Edgar Link unprocessable
chth-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img261520148_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending